Crescent Capital BDC (CCAP) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
26 Feb, 2026Executive summary
Q4 2025 net investment income was $0.45 per share, down from $0.46 in Q3, with net income per share rising to $0.23; NAV per share declined to $19.10 from $19.28.
Portfolio remains diversified and fundamentally healthy, with 184 companies across 18 industries and a fair value of $1,569 million.
Board declared a Q1 2026 regular dividend of $0.42 per share, payable April 15, 2026.
Portfolio is defensively positioned, with 91% in senior secured or unitranche first lien investments.
Financial highlights
Net investment income covered the base dividend by 107% in Q4.
Total net assets were $706 million at year-end, with total assets of $1.62 billion.
Debt-to-equity ratio was 1.25x (1.2x net of cash), within the 1.1x-1.3x target range.
Investment portfolio at fair value totaled $1.6 billion across 184 companies at year-end.
Weighted average yield on income-producing securities at cost was 10.0%, with 98% of debt investments floating rate.
Outlook and guidance
Management is reviewing fee structure and base dividend level to ensure long-term earnings durability amid lower rate expectations.
Expect to provide a more detailed update on strategic actions in May 2026.
Portfolio positioned defensively, emphasizing disciplined underwriting and active management.
Sufficient liquidity with $31.5 million in cash and $242 million undrawn debt capacity.
Latest events from Crescent Capital BDC
- Q2 2024 NII reached $0.59/share, NAV $20.30, with strong liquidity and stable credit.CCAP
Q2 20241 Feb 2026 - Q3 net investment income rose to $0.64 per share, with strong liquidity and low non-accruals.CCAP
Q3 202414 Jan 2026 - Q4 2024 featured lower NII, stable NAV, robust liquidity, and special dividends for 2025.CCAP
Q4 202424 Dec 2025 - Board urges ratification of Ernst & Young LLP as auditor, with 2024 fees totaling $841,150.CCAP
Proxy Filing2 Dec 2025 - Director elections and auditor ratification headline the 2025 annual meeting agenda.CCAP
Proxy Filing2 Dec 2025 - Stockholders will vote virtually on director elections and auditor ratification, with strong board oversight.CCAP
Proxy Filing2 Dec 2025 - Net investment income and NAV per share fell, but dividends and portfolio quality remain strong.CCAP
Q1 202526 Nov 2025 - Q2 2025 delivered strong income, stable NAV, and a $20M share repurchase program.CCAP
Q2 202523 Nov 2025 - Net investment income steady at $0.46 per share; NAV and net income per share declined.CCAP
Q3 202517 Nov 2025